|
|
| 5.44 Data as of Apr 17 |  -0.08 / -1.45%Today’s Change | 4.31 Today|||52-Week Range 10.86 | -23.70% Year-to-Date |
| Previous close | 5.52 |
| Today’s open | 5.49 |
| Day’s range | 5.33 - 5.70 |
| Volume | 373,373 |
| Average volume (3 months) | 813,095 |
| Market cap | $297.5M |
| Dividend yield | -- |
| Earnings growth (last year) | -85.29% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | 0.00% |
| P/E ratio | NM |
| Price/Sales | 5,460.76 |
| Price/Book | 7.27 |
| Today’s change | Today’s % change | |
|---|---|---|
| IDRAIdera Pharmaceutical... | -0.17 | -5.78% |
| SCMPSucampo Pharmaceutic... | -0.19 | -2.73% |
| ACHNAchillion Pharmaceut... | +0.04 | +1.43% |
| HRTXHeron Therapeutics I... | +0.45 | +4.01% |
| Next reporting date | May 28, 2014 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $50.0K |
| Annual profit (last year) | -$24.0M |
| Net profit margin | -48,017.12% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Michael Macaluso |
Chief Operating Officer Joshua R. Disbrow |
Corporate headquarters Greenwood Village, Colorado |
.
